α-2,8-Sialyltransferase Is Involved in the Development of Multidrug Resistance via PI3K/Akt Pathway in Human Chronic Myeloid Leukemia.
about
Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and OpportunitiesFunctional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells.Cell Recognition Molecule L1 Regulates Cell Surface Glycosylation to Modulate Cell Survival and Migration.Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.
P2860
α-2,8-Sialyltransferase Is Involved in the Development of Multidrug Resistance via PI3K/Akt Pathway in Human Chronic Myeloid Leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
α-2,8-Sialyltransferase Is Inv ...... uman Chronic Myeloid Leukemia.
@en
type
label
α-2,8-Sialyltransferase Is Inv ...... uman Chronic Myeloid Leukemia.
@en
prefLabel
α-2,8-Sialyltransferase Is Inv ...... uman Chronic Myeloid Leukemia.
@en
P2093
P2860
P921
P356
P1433
P1476
α-2,8-Sialyltransferase Is Inv ...... uman Chronic Myeloid Leukemia.
@en
P2093
Hongshuai Li
Huimin Zhou
Weijie Dong
Xiaoyan Miao
P2860
P356
10.1002/IUB.1351
P577
2015-02-01T00:00:00Z